- Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis2017 | First Faculty of Medicine
- Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis A Randomized Phase IIa Trial2015 | First Faculty of Medicine
